Understanding the business of vaccines: COVID-19

Maity, Rajdeepa and Raman, Rajeev (2021) Understanding the business of vaccines: COVID-19. Jindal Journal of Public Policy, 5 (1). pp. 27-35. ISSN 2277-8743

[thumbnail of Maity2021.pdf]
Maity2021.pdf - Published Version

Download (258kB) | Preview


Both the first vaccine produced to combat COVID-19, and the country of its production would not only have the financial edge over other countries, but also geopolitical supremacy. The current statistics of COVID-19 reported around hundreds of thousands of deaths in the world and counting. This article deals with the vaccine development process and costs related to COVID-19 and also highlights the significance of open alliances in the biotech sector in a post-COVID regime. This article focuses on ways in which the challenging worldwide health crises of the current pandemic can be overcome in distinctly local ways through open, transparent, and collaborative practices.

Item Type: Article
Keywords: COVID-19 | Vaccine | Open alliances | Biotech sector | Pandemic
Subjects: Social Sciences and humanities > Business, Management and Accounting > Business and International Management
Physical, Life and Health Sciences > Medicine
Social Sciences and humanities > Social Sciences > Health (Social sciences)
JGU School/Centre: Jindal Global Business School
Depositing User: Mr. Syed Anas
Date Deposited: 05 Apr 2022 09:52
Last Modified: 05 Apr 2022 09:52
Official URL: https://jgu.s3.ap-south-1.amazonaws.com/jsgp/JJPP+...
URI: https://pure.jgu.edu.in/id/eprint/2123


Downloads per month over past year

Actions (login required)

View Item
View Item